Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	260.98	125.02	34.63
Graham Fair Price	34.53	20.72	15.40
PEG	40.50	-0.05	0.04
Price/Book	3.82	0.85	0.82
Price/Cash Flow	316.41	-24.78	5.95
Prices/Earnings	49.81	-4.88	-9.72
Price/Sales	14.91	1.47	1.28
Price/FCF	316.41	-24.78	5.95
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-15.80	0.28	0.33
Operating Margin	-76.77	-0.01	0.05
ROA	-96.08	-0.01	< 0.005
ROE	-0.02	-0.04	-106.85
ROIC	< 0.005	< 0.005	-78.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	-0.04	130.24
Dividends QOQ	< 0.005	0.08	743.97
EBIT QOQ	0.37	-1.20	228.06
EPS QOQ	-2.62	-0.94	64.28
FCF QOQ	2.38	-1.23	-48.20
Revenue QOQ	0.07	-0.15	117.84
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	50.29	61.05	21.40
Days Sales Outstanding (DSO)	90.56	101.62	12.22
Inventory Turnover	1.79	1.47	-17.63
Debt/Capitalization	0.55	0.58	6.91
Quick Ratio	0.85	1.00	17.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.36	20.92	-6.47
Cash	4.79	6.01	25.61
Capex	-0.08	-0.08	0.69
Free Cash Flow	3.08	-0.72	-76.68
Revenue	14.34	12.12	-15.49
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.14	1.37	20.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.39	72.50	273.87
Naive Interpretation	Member

06 - Financial Health · Weak

Rating